A Blood Test for the Diagnosis of Multiple Sclerosis

Paola Giuliano,Giuliana La Rosa,Serena Capozzi,Emanuele Cassano,Simona Damiano,Francesco Habetswallner,Rosa Iodice,Maurizio Marra,Luigi Michele Pavone,Mario Quarantelli,Giuseppe Vitelli,Mariarosaria Santillo,Roberto Paternò
DOI: https://doi.org/10.3390/ijms25031696
IF: 5.6
2024-01-31
International Journal of Molecular Sciences
Abstract:Multiple sclerosis (MS) is an autoimmune chronic disease characterized by inflammation and demyelination of the central nervous system (CNS). Despite numerous studies conducted, valid biomarkers enabling a definitive diagnosis of MS are not yet available. The aim of our study was to identify a marker from a blood sample to ease the diagnosis of MS. In this study, since there is evidence connecting the serotonin pathway to MS, we used an ELISA (Enzyme-Linked Immunosorbent Assay) to detect serum MS-specific auto-antibodies (auto-Ab) against the extracellular loop 1 (ECL-1) of the 5-hydroxytryptamine (5-HT) receptor subtype 2A (5-HT2A). We utilized an ELISA format employing poly-D-lysine as a pre-coating agent. The binding of 208 serum samples from controls, both healthy and pathological, and of 104 serum samples from relapsing–remitting MS (RRMS) patients was tested. We observed that the serum-binding activity in control cohort sera, including those with autoimmune and neurological diseases, was ten times lower compared to the RRMS patient cohort (p = 1.2 × 10−47), with a sensitivity and a specificity of 98% and 100%, respectively. These results show that in the serum of patients with MS there are auto-Ab against the serotonin receptor type 2A which can be successfully used in the diagnosis of MS due to their high sensitivity and specificity.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a blood - based test method for diagnosing Multiple Sclerosis (MS). Although there are currently multiple studies being carried out, there is still a lack of effective biomarkers that can confirm the diagnosis of MS at present. The research purpose of this article is to identify a marker from blood samples that can simplify the diagnosis of MS. Specifically, since there is evidence indicating that the serotonin pathway is related to MS, the authors used enzyme - linked immunosorbent assay (ELISA) to detect MS - specific auto - antibodies (auto - Ab) against the extracellular loop 1 (ECL - 1) of the 5 - hydroxytryptamine receptor subtype 2A (5 - HT2A). By pre - coating poly - D - lysine on the microplate, the authors optimized the ELISA experiment to improve the signal intensity and detection sensitivity. The research results show that in the sera of patients with Relapsing - Remitting Multiple Sclerosis (RRMS), there are auto - antibodies against the 5 - HT2A receptor, and these auto - antibodies have very high sensitivity and specificity (98% and 100% respectively), so they can be successfully used for the diagnosis of MS.